Global Perphenazine Market Analysis and Forecast 2024-2030
Description
Global Perphenazine Market Analysis and Forecast 2024-2030
Summary
Perphenazine is a typical antipsychotic drug. Chemically, it is classified as a piperazinyl phenothiazine. Originally marketed in the US as Trilafon, it has been in clinical use for decades. Perphenazine is roughly five times as potent as chlorpromazine, thus perphenazine is considered a medium-potency antipsychotic.
According to APO Research, The global Perphenazine market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Perphenazine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Perphenazine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Perphenazine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Perphenazine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Perphenazine include Teva, Sandoz, Endo, Mylan, ZHPHARMA and Shandong Boshan Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Perphenazine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Perphenazine, also provides the sales of main regions and countries. Of the upcoming market potential for Perphenazine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Perphenazine sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Perphenazine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Perphenazine sales, projected growth trends, production technology, application and end-user industry.
Perphenazine segment by Company
Teva
Sandoz
Endo
Mylan
ZHPHARMA
Shandong Boshan Pharma
Perphenazine segment by Type
Oral Forms
Injectable Solution
Perphenazine segment by Application
Psychosis
Antiemetic
Perphenazine segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Perphenazine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Perphenazine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Perphenazine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Perphenazine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Perphenazine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Perphenazine sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
Table of Contents
198 Pages
- 1 Market Overview
- 1.1 Product Definition
- 1.2 Perphenazine Market by Type
- 1.2.1 Global Perphenazine Market Size by Type, 2019 VS 2023 VS 2030
- 1.2.2 Oral Forms
- 1.2.3 Injectable Solution
- 1.3 Perphenazine Market by Application
- 1.3.1 Global Perphenazine Market Size by Application, 2019 VS 2023 VS 2030
- 1.3.2 Psychosis
- 1.3.3 Antiemetic
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
- 2 Perphenazine Market Dynamics
- 2.1 Perphenazine Industry Trends
- 2.2 Perphenazine Industry Drivers
- 2.3 Perphenazine Industry Opportunities and Challenges
- 2.4 Perphenazine Industry Restraints
- 3 Global Market Growth Prospects
- 3.1 Global Perphenazine Revenue Estimates and Forecasts (2019-2030)
- 3.2 Global Perphenazine Revenue by Region
- 3.2.1 Global Perphenazine Revenue by Region: 2019 VS 2023 VS 2030
- 3.2.2 Global Perphenazine Revenue by Region (2019-2024)
- 3.2.3 Global Perphenazine Revenue by Region (2025-2030)
- 3.2.4 Global Perphenazine Revenue Market Share by Region (2019-2030)
- 3.3 Global Perphenazine Sales Estimates and Forecasts 2019-2030
- 3.4 Global Perphenazine Sales by Region
- 3.4.1 Global Perphenazine Sales by Region: 2019 VS 2023 VS 2030
- 3.4.2 Global Perphenazine Sales by Region (2019-2024)
- 3.4.3 Global Perphenazine Sales by Region (2025-2030)
- 3.4.4 Global Perphenazine Sales Market Share by Region (2019-2030)
- 3.5 US & Canada
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 Middle East, Africa and Latin America
- 4 Market Competitive Landscape by Manufacturers
- 4.1 Global Perphenazine Revenue by Manufacturers
- 4.1.1 Global Perphenazine Revenue by Manufacturers (2019-2024)
- 4.1.2 Global Perphenazine Revenue Market Share by Manufacturers (2019-2024)
- 4.1.3 Global Perphenazine Manufacturers Revenue Share Top 10 and Top 5 in 2023
- 4.2 Global Perphenazine Sales by Manufacturers
- 4.2.1 Global Perphenazine Sales by Manufacturers (2019-2024)
- 4.2.2 Global Perphenazine Sales Market Share by Manufacturers (2019-2024)
- 4.2.3 Global Perphenazine Manufacturers Sales Share Top 10 and Top 5 in 2023
- 4.3 Global Perphenazine Sales Price by Manufacturers (2019-2024)
- 4.4 Global Perphenazine Key Manufacturers Ranking, 2022 VS 2023 VS 2024
- 4.5 Global Perphenazine Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Perphenazine Manufacturers, Product Type & Application
- 4.7 Global Perphenazine Manufacturers Commercialization Time
- 4.8 Market Competitive Analysis
- 4.8.1 Global Perphenazine Market CR5 and HHI
- 4.8.2 2023 Perphenazine Tier 1, Tier 2, and Tier 3
- 5 Perphenazine Market by Type
- 5.1 Global Perphenazine Revenue by Type
- 5.1.1 Global Perphenazine Revenue by Type (2019 VS 2023 VS 2030)
- 5.1.2 Global Perphenazine Revenue by Type (2019-2030) & (US$ Million)
- 5.1.3 Global Perphenazine Revenue Market Share by Type (2019-2030)
- 5.2 Global Perphenazine Sales by Type
- 5.2.1 Global Perphenazine Sales by Type (2019 VS 2023 VS 2030)
- 5.2.2 Global Perphenazine Sales by Type (2019-2030) & (K MT)
- 5.2.3 Global Perphenazine Sales Market Share by Type (2019-2030)
- 5.3 Global Perphenazine Price by Type
- 6 Perphenazine Market by Application
- 6.1 Global Perphenazine Revenue by Application
- 6.1.1 Global Perphenazine Revenue by Application (2019 VS 2023 VS 2030)
- 6.1.2 Global Perphenazine Revenue by Application (2019-2030) & (US$ Million)
- 6.1.3 Global Perphenazine Revenue Market Share by Application (2019-2030)
- 6.2 Global Perphenazine Sales by Application
- 6.2.1 Global Perphenazine Sales by Application (2019 VS 2023 VS 2030)
- 6.2.2 Global Perphenazine Sales by Application (2019-2030) & (K MT)
- 6.2.3 Global Perphenazine Sales Market Share by Application (2019-2030)
- 6.3 Global Perphenazine Price by Application
- 7 Company Profiles
- 7.1 Teva
- 7.1.1 Teva Comapny Information
- 7.1.2 Teva Business Overview
- 7.1.3 Teva Perphenazine Sales, Revenue, Price and Gross Margin (2019-2024)
- 7.1.4 Teva Perphenazine Product Portfolio
- 7.1.5 Teva Recent Developments
- 7.2 Sandoz
- 7.2.1 Sandoz Comapny Information
- 7.2.2 Sandoz Business Overview
- 7.2.3 Sandoz Perphenazine Sales, Revenue, Price and Gross Margin (2019-2024)
- 7.2.4 Sandoz Perphenazine Product Portfolio
- 7.2.5 Sandoz Recent Developments
- 7.3 Endo
- 7.3.1 Endo Comapny Information
- 7.3.2 Endo Business Overview
- 7.3.3 Endo Perphenazine Sales, Revenue, Price and Gross Margin (2019-2024)
- 7.3.4 Endo Perphenazine Product Portfolio
- 7.3.5 Endo Recent Developments
- 7.4 Mylan
- 7.4.1 Mylan Comapny Information
- 7.4.2 Mylan Business Overview
- 7.4.3 Mylan Perphenazine Sales, Revenue, Price and Gross Margin (2019-2024)
- 7.4.4 Mylan Perphenazine Product Portfolio
- 7.4.5 Mylan Recent Developments
- 7.5 ZHPHARMA
- 7.5.1 ZHPHARMA Comapny Information
- 7.5.2 ZHPHARMA Business Overview
- 7.5.3 ZHPHARMA Perphenazine Sales, Revenue, Price and Gross Margin (2019-2024)
- 7.5.4 ZHPHARMA Perphenazine Product Portfolio
- 7.5.5 ZHPHARMA Recent Developments
- 7.6 Shandong Boshan Pharma
- 7.6.1 Shandong Boshan Pharma Comapny Information
- 7.6.2 Shandong Boshan Pharma Business Overview
- 7.6.3 Shandong Boshan Pharma Perphenazine Sales, Revenue, Price and Gross Margin (2019-2024)
- 7.6.4 Shandong Boshan Pharma Perphenazine Product Portfolio
- 7.6.5 Shandong Boshan Pharma Recent Developments
- 8 North America
- 8.1 North America Perphenazine Market Size by Type
- 8.1.1 North America Perphenazine Revenue by Type (2019-2030)
- 8.1.2 North America Perphenazine Sales by Type (2019-2030)
- 8.1.3 North America Perphenazine Price by Type (2019-2030)
- 8.2 North America Perphenazine Market Size by Application
- 8.2.1 North America Perphenazine Revenue by Application (2019-2030)
- 8.2.2 North America Perphenazine Sales by Application (2019-2030)
- 8.2.3 North America Perphenazine Price by Application (2019-2030)
- 8.3 North America Perphenazine Market Size by Country
- 8.3.1 North America Perphenazine Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
- 8.3.2 North America Perphenazine Sales by Country (2019 VS 2023 VS 2030)
- 8.3.3 North America Perphenazine Price by Country (2019-2030)
- 8.3.4 U.S.
- 8.3.5 Canada
- 9 Europe
- 9.1 Europe Perphenazine Market Size by Type
- 9.1.1 Europe Perphenazine Revenue by Type (2019-2030)
- 9.1.2 Europe Perphenazine Sales by Type (2019-2030)
- 9.1.3 Europe Perphenazine Price by Type (2019-2030)
- 9.2 Europe Perphenazine Market Size by Application
- 9.2.1 Europe Perphenazine Revenue by Application (2019-2030)
- 9.2.2 Europe Perphenazine Sales by Application (2019-2030)
- 9.2.3 Europe Perphenazine Price by Application (2019-2030)
- 9.3 Europe Perphenazine Market Size by Country
- 9.3.1 Europe Perphenazine Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
- 9.3.2 Europe Perphenazine Sales by Country (2019 VS 2023 VS 2030)
- 9.3.3 Europe Perphenazine Price by Country (2019-2030)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Russia
- 10 China
- 10.1 China Perphenazine Market Size by Type
- 10.1.1 China Perphenazine Revenue by Type (2019-2030)
- 10.1.2 China Perphenazine Sales by Type (2019-2030)
- 10.1.3 China Perphenazine Price by Type (2019-2030)
- 10.2 China Perphenazine Market Size by Application
- 10.2.1 China Perphenazine Revenue by Application (2019-2030)
- 10.2.2 China Perphenazine Sales by Application (2019-2030)
- 10.2.3 China Perphenazine Price by Application (2019-2030)
- 11 Asia (Excluding China)
- 11.1 Asia Perphenazine Market Size by Type
- 11.1.1 Asia Perphenazine Revenue by Type (2019-2030)
- 11.1.2 Asia Perphenazine Sales by Type (2019-2030)
- 11.1.3 Asia Perphenazine Price by Type (2019-2030)
- 11.2 Asia Perphenazine Market Size by Application
- 11.2.1 Asia Perphenazine Revenue by Application (2019-2030)
- 11.2.2 Asia Perphenazine Sales by Application (2019-2030)
- 11.2.3 Asia Perphenazine Price by Application (2019-2030)
- 11.3 Asia Perphenazine Market Size by Country
- 11.3.1 Asia Perphenazine Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
- 11.3.2 Asia Perphenazine Sales by Country (2019 VS 2023 VS 2030)
- 11.3.3 Asia Perphenazine Price by Country (2019-2030)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 China Taiwan
- 11.3.9 Southeast Asia
- 12 Middle East, Africa and Latin America
- 12.1 MEALA Perphenazine Market Size by Type
- 12.1.1 MEALA Perphenazine Revenue by Type (2019-2030)
- 12.1.2 MEALA Perphenazine Sales by Type (2019-2030)
- 12.1.3 MEALA Perphenazine Price by Type (2019-2030)
- 12.2 MEALA Perphenazine Market Size by Application
- 12.2.1 MEALA Perphenazine Revenue by Application (2019-2030)
- 12.2.2 MEALA Perphenazine Sales by Application (2019-2030)
- 12.2.3 MEALA Perphenazine Price by Application (2019-2030)
- 12.3 MEALA Perphenazine Market Size by Country
- 12.3.1 MEALA Perphenazine Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
- 12.3.2 MEALA Perphenazine Sales by Country (2019 VS 2023 VS 2030)
- 12.3.3 MEALA Perphenazine Price by Country (2019-2030)
- 12.3.4 Mexico
- 12.3.5 Brazil
- 12.3.6 Israel
- 12.3.7 Argentina
- 12.3.8 Colombia
- 12.3.9 Turkey
- 12.3.10 Saudi Arabia
- 12.3.11 UAE
- 13 Value Chain and Sales Channels Analysis
- 13.1 Perphenazine Value Chain Analysis
- 13.1.1 Perphenazine Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Perphenazine Production Mode & Process
- 13.2 Perphenazine Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Perphenazine Distributors
- 13.2.3 Perphenazine Customers
- 14 Concluding Insights
- 15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

